Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial

BACKGROUND AND HYPOTHESIS: Hyperuricaemia and gout are common in chronic kidney disease (CKD). We aimed to assess the effects of sodium-glucose co-transporter-2 (SGLT2) inhibition on uric acid (urate) and gout in patients with CKD. METHODS: The EMPA-KIDNEY trial randomised 6609 patients with CKD (es...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nephrol Dial Transplant
Main Authors: Mayne, Kaitlin J, Sardell, Rebecca J, Staplin, Natalie, Judge, Parminder K, Zhu, Doreen, Sammons, Emily, Cherney, David ZI, Green, Jennifer B., Levin, Adeera, Pontremoli, Roberto, Hauske, Sibylle J., Emberson, Jonathan, Preiss, David, Landray, Martin J, Baigent, Colin, Wanner, Christoph, Haynes, Richard, Herrington, William G
Formato: Artigo
Idioma:Inglês
Publicado em: 2024
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616479/
https://ncbi.nlm.nih.gov/pubmed/39277784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfae203
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados